期刊文献+

H7N9亚型禽流感病毒血凝素蛋白的真核表达及抗原性的鉴定 被引量:4

Eukaryotic expression of H7N9 subtype avian influenza virus hemagglutinin and identification of its antigenicity
原文传递
导出
摘要 目的:通过哺乳动物细胞表达出禽源H7N9流感表面HA蛋白,并鉴定其抗原性。方法:通过引物设计,利用融合PCR方法扩增得到H7N9禽流感HA基因,以p CAGGS为表达载体构建重组质粒p CAGGS-H7-thrombin。测序正确后将重组质粒转染293T细胞。经72 h后收获上清,通过镍柱和凝胶层析柱纯化后得到目的蛋白。Western blot和ELISA结果鉴定纯化的H7蛋白的抗原性。结果:293T细胞表达的上清经HisTrapTMHP纯化后过Superdex 200 10/300 GL分子筛,在洗脱体积达到11 m L左右出峰,由出峰位置判断其为H7三聚体。Western blot检测在60 ku左右有一条阳性条带,ELISA检测其对抗H7N9小鼠阳性血清有很高的反应值。试验成功表达禽流感病毒H7N9的H7蛋白,并且针对H7N9的阳性血清有较高的灵敏性,为进一步研究H7N9亚单位疫苗奠定了基础。 This study aims to express avian influenza virus (AIV) H7N9 surface glycoprotein H7 in mammalian cells and identify its anti- genicity. Firstly, we amplified HA gene fragment of AIV H7N9, and cloned into pCAGGS expression vector, thus obtaining plasmid pCAGGS-H7-thrombin. Then, the recombinant plasmid was transformed into 293T cells after sequencing. The supernatant was harvested af- ter 72 hours and the target protein was purified using nickel column and gellayer column. At last, the antigenieity of H7 was identified by Western blot and ELISA. The results showed that after the supernatant was purified through HistrapTM HP and Superdex 200 GL, H7 protein was successfully obtained. The molecular weight was demonstrated to be about 60ku by Western blot. ELISA result showed H7 had high re- sponse values with the positive sera from mice infected with H7N9. This study provides a foundation for further research on H7N9 subunit vaccine.
出处 《畜牧与兽医》 北大核心 2015年第5期16-19,共4页 Animal Husbandry & Veterinary Medicine
基金 天津市应用基础与前沿技术研究计划(14JCYBJC24400)
关键词 禽流感病毒 H7N9 血凝素蛋白 293T细胞 WESTERN BLOT ELISA avian influenza virus H7N9 hemagglutinin 293T cells Western blot ELISA
  • 相关文献

参考文献12

  • 1Prabakaran M,Rajesh Kumar S,Ashok Raj K V,et al.Crossprotective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes[J].Antiviral Research,2014,109:149-159.
  • 2Liu D,Shi W,Shi Y,et al.Origin and diversity of novel avian influenza A H7N9 viruses causing human infection:phylogenetic,structural,and coalescent analyses[J].The Lancet,2013,381:1926-1932.
  • 3Yu H,Cowling B J,Feng L,et al.Human infection with avian influenza A H7N9 virus:an assessment of clinical severity[J].The Lancet,2013,382:138-145.
  • 4Lsrisa Rudenko,Irina Isakova-Sivak,Andrey Rekstin.H7N9 can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic[J].Vaccine,2014,13:1-4.
  • 5Krammer F,Margine I,Hai R,et al.H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge[J].Journal of Virology,2014,88:2340-2343.
  • 6Couch R B,Patel S M,Wade-Bowers C L,et al.A randomized clinical trial of an inactivated avian influenza A(H7N7)vaccine[J].Plo S ONE,2012,7:e49704.
  • 7Klausberger M,Wilde M,Palmberger D,et al.One-shot vaccination with an insect cell-derived low-dose influenza A H7 viruslike particle preparation protects mice against H7N9 challenge[J].Vaccine,2014,32:355-362.
  • 8Fries L F,Smith G E and Glenn G M.A recombinant viruslike particle influenza A(H7N9)vaccine[J].The New England Journal of Medicine,2013,369:2564-256.
  • 9Solorzano A,Webby R J,Lager K M,et al.Mutations in the NS1protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs[J].Journal of Virology,2005,79:7535-7543.
  • 10Steel J,Lowen A C,Pena L,et al.Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza[J].Journal of Virology,2009,83:1742-1753.

同被引文献36

  • 1曹康,张卫东,李虹,李婉宜,蒋中华,庄永华,李明远.流感病毒血凝素基因HA1区的克隆及其真核表达载体的构建[J].中国人兽共患病杂志,2005,21(1):11-13. 被引量:6
  • 2I.iu GI., Zhang FF, Shi JZ, et ah A subunit vaccine candidate de rived from a classic HSN1 avianinfluenza virus in China protects fowls and BALB/c mice from lethalchallenge[J]. Vaccine, 2013, 31(46): 5398-404.
  • 3Kodihalli S, Sivanandan V, Nagaraja KV, et al. A type specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection [J]. Vaccine, 1994, 12 (15): 1467-72.
  • 4Zhang QY, Shi JZ, Deng GH, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet[J]. Science, 2013 (341): 410-4.
  • 5Klausberger M, Wilde M, Palmberger D, et al. One-shot vacci nation with an insect cell derived low dose influenza A H7 virus like particle preparation protects mice agai.nst H7N9 challenge [J]. Vaccine, 2014(32): 355-62.
  • 6Shahsava.ndi S, Salmanian AH, Ghorashi SA, et al. Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baeulovirus [J]. Mol Biol Rep, 2011 (38):3293- 8.
  • 7Fries LF, Smith GE, Glenn GM. A recombinant virus like par ticleinfluenzaA (H7N9) vaccine[J]. NEnglJ Med, 2013(369): 2564-6.
  • 8King JC, Coxb MM, Reisingerc K, et al. Evaluation of the safe- ty, reactogenicity and immunogenicity of FluBlok trivalent re- combinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6 - 59 months[J]. Vaccine, 2009(27): 6589-94.
  • 9Poomputsa KW, Kittel C, Egorov A, et al. Brief report Genera- tion of recombinant influenza virus using baculovirus delivery[J]. Virol Methods, 2003(110): 111-4.
  • 10Hu HX, Voss J, Zhang GL, et al. A human antibody recogniz-ing a conserved epitope of H5 hemagglutinin broadly highly pathogenic avian influenza H5N1 viruses [J]. 2012, 86(6): 2978- 89.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部